Citigroup’s Kite Pharma, Inc. KITE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-42,800
| Closed | -$7.7M | – | 7797 |
|
|
2017
Q3 | $7.7M | Buy |
42,800
+400
| +0.9% | +$55.7K | 0.01% | 1412 |
|
|
2017
Q2 | $4.39M | Buy |
42,400
+15,600
| +58% | +$1.27M | ﹤0.01% | 1809 |
|
|
2017
Q1 | $2.1M | Sell |
26,800
-200
| -0.7% | -$12.4K | ﹤0.01% | 2431 |
|
|
2016
Q4 | $1.21M | Buy |
27,000
+1,600
| +6% | +$78.5K | ﹤0.01% | 3482 |
|
|
2016
Q3 | $1.42M | Buy |
25,400
+8,300
| +49% | +$462K | ﹤0.01% | 2855 |
|
|
2016
Q2 | $855K | Sell |
17,100
-600
| -3% | -$29.5K | ﹤0.01% | 3113 |
|
|
2016
Q1 | $813K | Sell |
17,700
-9,000
| -34% | -$436K | ﹤0.01% | 3581 |
|
|
2015
Q4 | $1.65M | Sell |
26,700
-10,200
| -28% | -$718K | ﹤0.01% | 2637 |
|
|
2015
Q3 | $2.06M | Buy |
36,900
+6,200
| +20% | +$390K | ﹤0.01% | 2422 |
|
|
2015
Q2 | $1.87M | Buy |
30,700
+25,100
| +448% | +$1.43M | ﹤0.01% | 2580 |
|
|
2015
Q1 | $323K | Buy |
+5,600
| New | +$375K | ﹤0.01% | 4124 |
|
Citigroup's KITE Position: Q4 2017 in Review
Citigroup sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 356,484 shares — an estimated $64.1M sold.
Citigroup first reported a position in KITE in Q3 2014 and held it in 13 quarters. The position peaked at $64.1M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.
- Citigroup reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
- Citigroup sold 356,484 Kite Pharma, Inc. shares in Q4 2017, an estimated $64.1M.
- Citigroup first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 13 quarters.
- Citigroup's Kite Pharma, Inc. position peaked at $64.1M in Q3 2017.
- 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.
Based on Citigroup's 13F filing for Q4 2017, filed 12 Feb 2018.